Literature DB >> 8603694

Cyclic aristeromycin diphosphate ribose: a potent and poorly hydrolysable Ca(2+)-mobilising mimic of cyclic adenosine diphosphate ribose.

V C Bailey1, S M Fortt, R J Summerhill, A Galione, B V Potter.   

Abstract

Cyclic aristeromycin diphosphate ribose, a carbocyclic analogue of cyclic adenosine diphosphate ribose, was synthesised using a chemo-enzymatic route involving activation of aristeromycin 5'-phosphate by diphenyl phosphochloridate. The calcium-releasing properties of this novel analogue were investigated in sea urchin egg homogenates. While cyclic aristeromycin diphosphate ribose has a calcium release profile similar to that of cyclic adenosine diphosphate ribose (EC50 values are 80 nM and 30 nM, respectively), it is degraded significantly more slowly (t1/2 values are 170 min and 15 min, respectively) and may, therefore, be a useful tool to investigate the activities of cyclic adenosine diphosphate ribose.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603694     DOI: 10.1016/0014-5793(95)01515-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

Review 2.  Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.

Authors:  H C Lee; C Munshi; R Graeff
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

3.  Cyclic ADP-ribose and calcium-induced calcium release regulate neurotransmitter release at a cholinergic synapse of Aplysia.

Authors:  J P Mothet; P Fossier; F M Meunier; J Stinnakre; L Tauc; G Baux
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

4.  Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist.

Authors:  Joanna M Swarbrick; Barry V L Potter
Journal:  J Org Chem       Date:  2012-01-31       Impact factor: 4.354

5.  'Click cyclic ADP-ribose': a neutral second messenger mimic.

Authors:  Joanna M Swarbrick; Richard Graeff; Clive Garnham; Mark P Thomas; Antony Galione; Barry V L Potter
Journal:  Chem Commun (Camb)       Date:  2014-01-23       Impact factor: 6.222

6.  Synthesis and Biological Evaluation of a New Structural Simplified Analogue of cADPR, a Calcium-Mobilizing Secondary Messenger Firstly Isolated from Sea Urchin Eggs.

Authors:  Stefano D'Errico; Nicola Borbone; Bruno Catalanotti; Agnese Secondo; Tiziana Petrozziello; Ilaria Piccialli; Anna Pannaccione; Valeria Costantino; Luciano Mayol; Gennaro Piccialli; Giorgia Oliviero
Journal:  Mar Drugs       Date:  2018-03-10       Impact factor: 5.118

7.  Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".

Authors:  Joanna M Watt; Richard Graeff; Mark P Thomas; Barry V L Potter
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 8.  25 Years of Collaboration with A Genius: Deciphering Adenine Nucleotide Ca2+ Mobilizing Second Messengers Together with Professor Barry Potter.

Authors:  Andreas H Guse
Journal:  Molecules       Date:  2020-09-15       Impact factor: 4.411

9.  CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.

Authors:  Christelle Moreau; Qun Liu; Richard Graeff; Gerd K Wagner; Mark P Thomas; Joanna M Swarbrick; Satoshi Shuto; Hon Cheung Lee; Quan Hao; Barry V L Potter
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.

Authors:  Joanna M Swarbrick; Richard Graeff; Hongmin Zhang; Mark P Thomas; Quan Hao; Barry V L Potter
Journal:  J Med Chem       Date:  2014-10-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.